Industry reports
Editor highlights

Global Therapy Industry Market Research Reports, April 2014

You might be interested in: therapeutics, rnai therapeutics, immunotherapy, more »

» View Public Reports

1-30 of 43 reports

Company Report: Therapeutics in Canada and The United States for Year 2014

  • Company report
  • March 2014
  • 2 pages

... To announce that the united states securities and exchange commission (sec) has issued an order in the matter of pacific therapeutics ltd. &Amp;#8220;declaring registration effective pursuant to section 12(g ...

  • Industries: Therapy
  • Countries: Canada, United States, World

World Pain Management Therapeutics Industry Brief

  • Industry report
  • July 2013
  • 13 pages

... In 2011, of the total pain management therapeutics market by therapeutic class. This class comprises of some of the oldest known painkillers such as diclofenac, ibuprofen and aspirin (acetylsalicylic acid ...

  • Industries: Therapy
  • Countries: World

Global Therapy Sector Overview

  • Industry report
  • May 2013
  • 22 pages

... Medicine: definition 2 The tailoring of medical treatment to the specific characteristics of each patient. [It] does not literally mean the creation of drugs or medical devices that are unique ...

  • Industries: Therapy
  • Countries: World

World Therapeutics Industry Brief

  • Industry report
  • March 2013
  • 16 pages

... The peptide therapeutics market is also segmented based on geography into north america, europe, asia and rest of the world (row) regions. The market for all these geographical regions is provided ...

  • Industries: Therapy
  • Countries: World

Investor presentation: Therapy for Year 2013

  • Company report
  • March 2013
  • 29 pages
  • Industries: Therapy
  • Countries: World

Cyberonics Inc. - Investment Analysis, March 2013

  • Company report
  • March 2013
  • 6 pages
  • by Corporation
  • Industries: Therapy
  • Countries: World, Europe, United States

U.S. Therapy Industry Brief

  • Industry report
  • February 2013
  • 21 pages

... Pro- inflammatory cytokine gene transcription drm02 tnf Gm- csf il-8 icam Attractive target product profile Novel topical kinase inhibitor that inhibits multiple inflammatory pathways ...

  • Industries: Therapy
  • Countries: World, United States

Therapy in Malaysia and Philippines : Innovation and Technology Trends

  • Industry report
  • February 2013
  • 2 pages

... S kinase inhibitor market is 5% of the whole emerging market region and also ape1 inhibitor would value the same as the kinase inhibitor market considering its roles in cancer treatment, ape1 inhibitor ...

  • Industries: Therapy
  • Countries: Malaysia, Philippines, World

Company Report: Therapy in Europe and The United States for Year 2012

  • Company report
  • October 2012
  • 6 pages

... immunotherapy) market; recent and upcoming regulatory catalysts should support this, driving future revenue growth. The fda clinical hold lift on pollinex quattro (pq) grass permits allergy to go ahead with us ...

  • Industries: Therapy
  • Countries: Germany, Europe, United States

Investor presentation: Therapy in The United States and India for Year 2012

  • Company report
  • July 2012
  • 29 pages

... As well as strong growth of radiation therapy in bric countries guidance - high visibility on iba s revenue circle7 iba anticipates low single digit growth in group revenues in 2013 circle7 confident ...

  • Industries: Therapy
  • Countries: United States, India, World

Company Report: Therapy in The United States and Europe for Year 2012

  • Company report
  • May 2012
  • 19 pages
  • by Corporation

... Street, llc interventional options, they don't have good options in terms of surgical therapy, and they really are at the max of what pharmacologics can do for the heart. As you know, there are only about 5 ...

  • Industries: Therapy
  • Countries: United States, Europe

Company Report: Therapy in The United States and Belgium for Year 2012

  • Company report
  • May 2012
  • 36 pages

... Tomography) and in cancer therapy (radiation therapy). In both applications, radiation is used to improve the outcome of the patient. However radiation has to be applied wisely and carefully in order ...

  • Industries: Therapy
  • Countries: United States, Belgium, World

The Swedish Radiation Therapy Sector Brief

  • Industry report
  • March 2012
  • 3 pages

... A measuring instrument for use in radiation therapy treatment of cancer. The measuring device automatically and safely measures exactly how much and where the radiation therapy treatment should be applied ...

  • Industries: Therapy
  • Countries: Europe, Sweden, World

Company Report: Therapy in Belgium and The United States for Year 2012

  • Company report
  • March 2012
  • 12 pages

... On disposal of bioassays business Following restructuring, iba equipment now operating as two segments, proton therapy / accelerators and dosimetry. Bioassays reclassified as Held for sale And excluded ...

  • Industries: Therapy
  • Countries: Belgium, United States, World

Company Report: Therapy in Belgium and The United States for Year 2012

  • Company report
  • March 2012
  • 5 pages

... Conversion rate of the existing backlog this quarter that is related to production planning and is not unusual for this type of activity. No new orders were signed in q1 for proton therapy projects ...

  • Industries: Therapy
  • Countries: Belgium, World, United States

Company Report: Therapy in Europe for Year 2012

  • Company report
  • March 2012
  • 2 pages
  • Industries: Therapy
  • Countries: Europe

Investor presentation: Immunotherapy in The United States and Europe for Year 2012

  • Company report
  • March 2012
  • 26 pages

... Another year of growth, supporting global leadership in allergen immunotherapy annual results 8 march 2013 disclaimer / forward-looking statement this presentation contains forward ...

  • Industries: Therapy
  • Countries: United States, France, Europe

Company Report: Therapy in Europe and The United States for Year 2012

  • Company report
  • March 2012
  • 4 pages
  • Industries: Therapy
  • Countries: Europe, United States, Spain

Company Report: Therapy in The United States for Year 2012

  • Company report
  • March 2012
  • 10 pages
  • Industries: Therapy
  • Countries: United States, Europe, World

Company Report: Therapy in Germany and Switzerland for Year 2012

  • Company report
  • February 2012
  • 2 pages

... Not to commission the particle therapy facility at the university hospital schleswig-holstein in kiel. The reason given by the company is the unlikelihood that the project would make a profit. Particle therapy ...

  • Industries: Therapy
  • Countries: Germany, World, Switzerland

SVB Financial Group - Company Report for Year 2012

  • Company report
  • January 2012
  • 2 pages
  • by Corporation

... For physiology or medicine. rnai therapeutics, such as "sirnas," require delivery technology to be effective systemically. Tekmira believes its lnp technology represents the most widely adopted delivery ...

  • Industries: Therapy
  • Countries: Canada, United States, World

Vaccination Market Statistics in South America

  • Industry report
  • January 2012
  • 26 pages

... Regionalized vaccination also implemented fmd main tools Mass vaccination (1) Delivery through public-private partnerships Quality control throughout vaccination chain vaccine production vaccine ...

  • Industries: Therapy
  • Countries: Brazil, South America, Uruguay

Company Report: Rnai Therapeutics in North America for Year 2012

  • Company report
  • January 2012
  • 12 pages
  • by Corporation

... For physiology or medicine. rnai therapeutics, such as "sirnas," require delivery technology to be effective systemically. Tekmira believes its lnp technology represents the most widely adopted delivery ...

  • Industries: Therapy
  • Countries: United States, Canada, North America

New York Botanical Garden Press - Company Report for Year 2012

  • Company report
  • January 2012
  • 20 pages

... Required between industry, payers and governments for a productive personalized medicine market 94 table 7.3: Quick facts - business model recommendations for diagnostic, pharmaceutical ...

  • Industries: Therapy
  • Countries: United States, Europe, World

Company Report: Immunotherapy in Europe and Canada for Year 2011

  • Company report
  • March 2011
  • 2 pages
  • Industries: Therapy
  • Countries: Europe, Czech Republic, Canada

Therapeutics Industry in Japan, Europe and The United States

  • Industry report
  • March 2011
  • 5 pages

... Increasing uptake of benlysta, uloric, krystexxa, and the launch of oral tofacitinib to spur growth. The report provides insights into the rheumatology therapeutics market forecasts until 2018 and examines ...

  • Industries: Therapy
  • Countries: Japan, Europe, United States

World Chemotherapy Industry Brief

  • Industry report
  • January 2011
  • 8 pages

... With market share for each- hormone therapy: - subcategories include corticosteroids, hormone agonists/antagonists, aromatase inhibitors and serms - brands such as arimidex, casodex, zoladex, femara and lupron ...

  • Industries: Therapy
  • Countries: World

Company Report: Therapy for Year 2010

  • Company report
  • September 2010
  • 43 pages

... Bank of america merrill lynch global healthcare conference 2010 september 17, 2010 fresenius medical care the world s leading renal therapy company circlecopyrt 2010 fresenius medical care ag & co ...

  • Industries: Therapy
  • Countries: World

The European Health Insurance and Therapy Industries Brief

  • Industry report
  • August 2010
  • 12 pages
  • by Intergovernmental Agency

... Task force on major and chronic diseases the netherlands institute for health services research project output related to echi indicator lists december 2006 May 2007 ...

  • Industries: Health Insurance, Therapy
  • Countries: Europe

Company Report: Therapy for Year 2010

  • Company report
  • August 2010
  • 36 pages

... Fresenius medical care the world s leading renal therapy company ...

  • Industries: Therapy
  • Countries: World

» Purchase Premium Reports (From $ 250 - $ 5 995)

About 3 700 reports
OpportunityAnalyzer: Nonalcoholic Steatohepatitis (NASH) - Opportunity Analysis and Forecasts to 2017 - Event-Driven Update

OpportunityAnalyzer: Nonalcoholic Steatohepatitis (NASH) - Opportunity Analysis and Forecasts to 2017 - Event-Driven Update

  • $ 5 995
  • Industry report
  • March 2014
  • by Global Data

OpportunityAnalyzer: Nonalcoholic Steatohepatitis (NASH) - Opportunity Analysis and Forecasts to 2017 - Event-Driven Update Summary GlobalData has released its new Opportunity Analyzer report, “Oppo ...


ReportLinker is a professional search engine that provides an easy access to 1,2 million market research reports and industry statistics published by 200,000 authoritative sources.